Financials data is unavailable for this security.
View more
Year on year AxoGen Inc grew revenues 14.74% from 138.58m to 159.01m while net income improved from a loss of 28.95m to a smaller loss of 21.72m.
Gross margin | 76.13% |
---|---|
Net profit margin | -7.91% |
Operating margin | -4.70% |
Return on assets | -7.40% |
---|---|
Return on equity | -14.51% |
Return on investment | -8.49% |
More ▼
Cash flow in USDView more
In 2023, AxoGen Inc increased its cash reserves by 71.93%, or 15.49m. Cash Flow from Investing totalled 19.25m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 5.72m for operations while cash generated from financing totalled 1.95m.
Cash flow per share | -0.1689 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.26 |
---|---|
Tangible book value per share | 2.14 |
More ▼
Balance sheet in USDView more
Current ratio | 3.74 |
---|---|
Quick ratio | 2.47 |
Total debt/total equity | 0.4757 |
---|---|
Total debt/total capital | 0.3224 |
More ▼